Skip to content
goodwin-final-colorColor Goodwin logo
  • Manufacturing Solutions
    • Analytical Method Development
    • Clinical GMP Manufacturing Services
    • Upstream Development
    • Downstream Development
    • Aseptic Fill and Finish
    • Bioconjugation
  • Support Solutions
    • Regulatory & CMC Support
    • Quality Control
    • Quality Assurance
    • Project Management
    • Biotechnology Consulting Services
    • Cell Line Development
  • Applications
    • COVID-19
    • Exosomes
    • Biosimilars & Biobetters
    • Multispecific Antibodies & Antibody Fragments
  • About
    • Who We Are
    • Leadership
    • Board of Directors
    • Facilities and Location
    • Why Goodwin Biotechnology?
    • Goodwin Awards
    • Collaborations & Partnerships
    • Goodwin Biotechnology in the News
      • Press Releases
      • Upcoming Events
      • In the News
      • Publications & Patents
    • Careers
  • Contact Us
  • Manufacturing Solutions
    • Analytical Method Development
    • Clinical GMP Manufacturing Services
    • Upstream Development
    • Downstream Development
    • Aseptic Fill and Finish
    • Bioconjugation
  • Support Solutions
    • Regulatory & CMC Support
    • Quality Control
    • Quality Assurance
    • Project Management
    • Biotechnology Consulting Services
    • Cell Line Development
  • Applications
    • COVID-19
    • Exosomes
    • Biosimilars & Biobetters
    • Multispecific Antibodies & Antibody Fragments
  • About
    • Who We Are
    • Leadership
    • Board of Directors
    • Facilities and Location
    • Why Goodwin Biotechnology?
    • Goodwin Awards
    • Collaborations & Partnerships
    • Goodwin Biotechnology in the News
      • Press Releases
      • Upcoming Events
      • In the News
      • Publications & Patents
    • Careers
  • Contact Us

In the News

Home / Who We Are / Goodwin Biotechnology in the News / In the News

CMOs Hold Their Ground in Troubled Times

  • March 1, 2009

CMOs Focused on Meeting Needs and Time Lines

  • October 1, 2007

Innovations in Pharmaceutical Technology – James Fenno, VP of Regulatory and Quality discusses the Challenges facing small companies for the manufacture of antibodies.

  • September 1, 2007

Neogenix Oncology, Inc. Selects Goodwin Biotechnology, Inc. For Manufacturing Of Its Monoclonal Antibody

  • July 5, 2007

In-Pharma coverage of GBI expansion and growth

  • May 14, 2007

Pharmabiz coverage of Globalization in the Biotech industry

  • December 21, 2006

Goodwin Biotechnology expands in Plantation

  • June 16, 2006

US-based Goodwin in talks with leading Indian BT cos, plans R&D base in India

  • April 11, 2006

Goodwin Bio to partner with Indian biopharma cos for contract manufacturing

  • February 8, 2006
Previous 1 2

1850 N.W. 69th Avenue Plantation, FL 33313 USA 954-321-5300

  • Facebook
  • Twitter
  • LinkedIn
  • Manufacturing Solutions
    • Analytical Method Development
    • Clinical GMP Manufacturing Services
    • Upstream Development
    • Downstream Development
    • Aseptic Fill and Finish
    • Bioconjugation
  • Support Solutions
    • Regulatory & CMC Support
    • Quality Control
    • Quality Assurance
    • Project Management
    • Biotechnology Consulting Services
    • Cell Line Development
  • Applications
    • COVID-19
    • Exosomes
    • Biosimilars & Biobetters
    • Multispecific Antibodies & Antibody Fragments
  • Who We Are
    • Leadership
    • Board of Directors
    • Facilities & Location
    • Why Goodwin Biotechnology?
    • Goodwin Awards
    • Collaborations & Partnerships
    • Goodwin Biotechnology in the News
    • Careers
    • Blog
© 2022 Goodwin Biotechnology Inc. All Rights Reserved.
  • Privacy Policy
  • Sitemap